EPSON (EARLY DETECTION FOR PARKINSON DISEASE) TINJAUAN PUSTAKA DISBIOSIS GUT MICROBIAL SEBAGAI POTENSI DETEKSI DINI PARKINSON MELALUI PEMERIKSAAN FESES

Qanita Adzkia Novindra, Fildzah Ghaisani Alifah, Nadia Alfi Syariafah

Abstract


Parkinson disease (PD) merupakan salah satu penyakit neuro degeneratif yang tidak dapat disembuhkan dengan manifetasi klinis berupa gangguan pada gerak motorik. Saat ini diagnosis pada penyakit parkinson masih didasarkan pada gejala motorik yang timbul. Deteksi dini pada PD dibutuhkan sehingga pasien akan mendapat penanganan sejak dini untuk mencegah patogenesis kerusakan neuron di substansia nigra. Berdasarkan penelitian, diketahui bahwa gejala berupa disfungsi usus muncul 5-7 tahun sebelum terjadi gangguan motorik pada pasien PD. Timbulnya disfungsi usus ini memiliki keterkaitan dengan ketidak seimbangan komposisi mikrobiota usus (GM). Tujuan dari literatur review ini adalah melakukan studi literatur mengenai hubungan antara komposisi GM dengan patogenesis parkinson disease sebagai dasar deteksi dini parkinson disease. Metode yang digunakan dalam proses literature review ini adalah metode PRISMA, dimana dari 261 sumber awal yang sudah penulis dapatkan sesuai dengan keyword menggunakan metode Boolean, terdapat 229 sumber yang di eksklusi karena tidak memenuhi kriteria inklusi yang ditetapkan penulis. Dari hasil dan pembahasan didapatkan bahwa disbiosis bakteri pada gastrointestinal tract adalah proses yang mengawali patogenesis dari PD. Hal ini dibuktikan dengan adanya peningkatan dua kali lipat konsentrasi Indoxyl Sulfat urin (indikator disbiosis mikroba) pada pasien. Terdapat pola unik perubahan komposisi mikroba saluran pencernaan, yaitu perubahan β- diversity, peningkatan pertumbuhan koloni bakteri genus Akkermansia, Genus Lactobacillus, dan Famili Enterobacteriaceae;dan penurunan pertumbuhan Genus Faecalibacterium, dan Genus Provotella. Kesimpulan yang didapatkan adalah perubahan komposisi bakteri di saluran pencernaan merupakan salah satu pemicu yang mengawali patogenesis PD dan bahwa pola unik perubahan komposisi gut microbial memiliki potensi untuk dijadikan deteksi dini Parkinson Disease.


Keywords


Parkinson disease, Gut Microbial, Disbiosis, Early Detection

Full Text:

PDF

References


Gunawan G, Dalhar M, Kurniawan SN. Parkinson And Stem Cell Therapy. Malang Neurology Journal. 2017 ; 3 :39–46. doi: 10.21776/ub.mnj.2017.003.01.7

Forsythe P, Kunze WA. Voices from within:gut microbes and the CNS. Cell Mol Life Sci. 2013; 70:55–69 doi: 10.1007/s00018-012-1028-z

Samuels AM. Manual of Neurologi Therapeutics. Philadeplhia: Lippincott Williams & Walkins : 2017

Gao, Xiang, et al. A prospective study of bowel movement frequency and risk of Parkinson’s‎ disease. American journal of epidemiology. 2011; 174(5): 546-551.doi:10.1093/aje/kwr119

Mulak A, Bonaz B. Brain-Gut-Microbiota Axis in Parkinson's Disease. World J Gastroenterol. 2015; 21:10609–20.doi: 10.3748/wjg.v21.i37.10609.

Yang, Dongming, et al. The Role of the GuMicrobiota in the Pathogenesis of Parkinson's Disease. Frontiers in neurology. 2019; 10 : 1-13 doi: 10.3389/fneur.2019.01155

Spielman, Lindsay Joy; Gibson, Deanna Lynn; Klegeris, Andis. Unhealthy Gut, Unhealthy Brain: The Role Of The Intestinal Microbiota In Neurodegenerative Diseases. Neurochemistry international. 2018; 120:149-163.doi: 10.1016/j.neuint.2018.08.005

Holmqvist, Staffan, Et Al. Direct Evidence Of Parkinson Pathology Spread from The Gastrointestinal Tract to The Brain in Rats.Acta Neuropathologica. 2014; 128(6): 805-20 doi :10.1007/s00401-014-1343-6

Braak H, Vos Raid, Bohl J, Tredici KD. Inclusions in Meissner’s‎ And Auerbach’s‎ Plexuses in Cases Staged For Parkinson’s‎ Disease-Related Brain Pathology. Neurosci Lett. 2006; 396:67–72. doi: 10.1016/J.Neulet.2005.11.012

Cassani, Erica, et al. Increased Urinary Indoxyl Sulfate (Indican): New Insights into Gut Dysbiosis in Parkinson's Disease. Parkinsonism & Related Disorders. 2015;21(4) : 389-393 doi: 10.1016/j.parkreldis.2015.02.004

Baratawidjaja, Karnen G., Rengganis, Iris.

Imunologi Dasar Edisi ke Sebelas. Jakarta: Balai Penerbit FKUI : 2014. h 336-337

SNCA gene synuclein alpha [internet].National Library of Medicine.. 2020 [cited 30 juni 2020]. Available from:http://www.nlm.nih.gov/medlineplus/hantavirusinfections.html

Guyton, A. C., Hall, J. E. Buku Ajar Fisiologi Kedokteran. Edisi 13. Jakarta : EGC: 2019. h1022.

Herath, M., Hosie, S., Bornstein, J. C., Franks, A. E., & Hill-Yardin, E. L. The Role of the Gastrointestinal Mucus System in Intestinal Homeostasis: Implications for Neurological Disorders. Frontiers in Cellular and Infection Microbiology. 2020; 10: 248. doi:10.3389/fcimb.2020.00248

Chen Peng (ed.). Gut Microbiota and Pathogenesis of Organ Injury. Springer Singapore. : 2020.

Zulissetiana, Eka Febri; Suryani, Puji Rizki. Degenerasi Kognitif pada Stres Kronik. Jurnal Kedokteran Universitas Lampung. 2016; 1(2): 418-423.

Lisdiana. Regulasi Kortisol Pada Kondisi Stres dan Addiction. Biosantifika. 2012; 4(1) :18- 26.

Bartels, T., Choi, J. G., & Selkoe,‎ D.‎ J.‎ α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation.Nature. 2011; 477(7362): 107–110.doi : 10.1038/nature10324

Holmqvist, S., Chutna, O., Bousset, L., Aldrin Kirk, P., Li, W., Björklund, T., Wang, Z. Y., Roybon, L., Melki, R., & Li, J. Y. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta neuropathologica. 2014; 128(6): 805–820 doi: 10.1007/s00401-014-1343-6

Keshavarzian, Ali, et al. Colonic Bacterial Composition in Parkinson's Disease. Movement Disorders. 2015; 30(10) :1351-1360. doi : 10.1002/mds.26307

Gerhardt, Sara; Mohajeri, M. Hasan. Changes of Colonic Bacterial Composition in Parkinson’s‎ Disease and Other Neurodegenerative Diseases. Nutrients. 2018;

(6) : 708 doi: 10.3390/nu10060708

Petrov, V. A., et al. Analysis of Gut Microbiota in‎Patients‎with‎Parkinson’s‎Disease. Bulletin of Experimental biology and medicine. 2017;162(6): 734-737.doi: 10.1007/s10517-017-3700-7

Li, Wei, et al. Structural Changes of Gut Microbiota‎ in‎ Parkinson’s‎ Disease‎ and Its Correlation with Clinical Features. Science China Life Sciences. 2017; 60(11): 1223-1233. doi: 10.1007/s11427-016-9001-4

Hill‐Burns, Erin M., et al. Parkinson's Disease And Parkinson's Disease Medications Have Distinct Signatures of The Gut Microbiome. Movement Disorders. 2017; 32(5): 739-749. doi: 10.1002/mds.26942

Bedarf, Janis R., et al. Functional Implications of Microbial and Viral Gut Metagenome Changes in Early Stage L-DOPA-Naïve Parkinson’s‎ Disease Patients. Genome medicine. 2017; 9(1) : 1-1 doi: 10.1186/s13073-017-0428-y

Unger, Marcus M., et al. Short Chain Fatty Acids and Gut Microbiota Differ between Patients with Parkinson's Disease and Age- Matched Controls. Parkinsonism & related disorders. 2016; 32: 66-72 doi: 10.1016/j.parkreldis.2016.08.019

Heintz‐Buschart, Anna, et al. The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder. Movement disorders, 2018, 33.1: 88- 98. doi: 10.1002/mds.27105

Lin CH, et al. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease. J Neuroinflammation. 2019;16:129.

doi: 10.1186/s12974-019-1528-y

Li, Fang, et al. Alteration of the fecal microbiota in North-Eastern Han Chinese population‎ with‎ sporadic‎ Parkinson’s‎ disease. Neuroscience letters. 2019; 707:134297.doi: 10.1016/j.neulet.2019.134297

Scheperjans, Filip, et al. Gut microbiota are related to Parkinson's disease and clinical phenotype.Movement Disorders, 2015, 30.3:350-358. doi: 10.1002/mds.26069

Kowalska-Duplaga, Kinga, et al. Differences in the intestinal microbiome of healthy children and‎ patients‎ with‎ newly‎ diagnosed‎ Crohn’s‎ disease. Scientific reports. 2019; 9(1): 1-11. dos:10.3389/fnmol.2019.00171

Magistrelli,‎ Luca‎ et‎ al.‎ “Probiotics‎ May‎ Have‎ Beneficial Effects in Parkinson's Disease: In vitro Evidence.”‎Frontiers in immunology vol. 10 969. 7 May. 2019, doi: 10.3389/fimmu.2019.00969




DOI: https://doi.org/10.26618/aimj.v4i1.4980

Refbacks

  • There are currently no refbacks.


Copyright (c) 2021 Qanita Adzkia Novindra, Fildzah Ghaisani Alifah, Nadia Alfi Syariafah

Creative Commons License
Al-Iqra Medical Journal: Jurnal Ilmiah Kedokteran under by Creative Commons Attribution-NoDerivatives 4.0 International License.